NASDAQ:SDGR Schrödinger (SDGR) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free SDGR Stock Alerts $23.72 -0.33 (-1.37%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$23.53▼$24.1550-Day Range$23.19▼$33.0952-Week Range$20.76▼$59.24Volume568,988 shsAverage Volume867,074 shsMarket Capitalization$1.72 billionP/E RatioN/ADividend YieldN/APrice Target$42.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Schrödinger alerts: Email Address Schrödinger MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside80.4% Upside$42.80 Price TargetShort InterestBearish8.88% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 15 Articles This WeekInsider TradingSelling Shares$102,395 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.70) to ($1.66) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.81 out of 5 starsMedical Sector387th out of 903 stocksPharmaceutical Preparations Industry173rd out of 420 stocks 4.3 Analyst's Opinion Consensus RatingSchrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageSchrödinger has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Schrödinger's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.88% of the outstanding shares of Schrödinger have been sold short.Short Interest Ratio / Days to CoverSchrödinger has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in Schrödinger has recently increased by 2.88%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSchrödinger does not currently pay a dividend.Dividend GrowthSchrödinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SDGR. Previous Next 2.2 News and Social Media Coverage News SentimentSchrödinger has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Schrödinger this week, compared to 3 articles on an average week.Search Interest12 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.MarketBeat FollowsOnly 11 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is a decrease of -8% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Schrödinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $102,395.00 in company stock.Percentage Held by InsidersOnly 7.60% of the stock of Schrödinger is held by insiders.Percentage Held by Institutions79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Schrödinger's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Schrödinger are expected to grow in the coming year, from ($2.70) to ($1.66) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrödinger is -12.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrödinger is -12.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSchrödinger has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Schrödinger's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Schrödinger Stock (NASDAQ:SDGR)Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Read More SDGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SDGR Stock News HeadlinesMay 6, 2024 | americanbankingnews.comSchrödinger, Inc. (NASDAQ:SDGR) Receives Average Rating of "Moderate Buy" from AnalystsMay 3, 2024 | markets.businessinsider.comMaintaining Neutral: Assessing Schrodinger’s Mixed Q1 Performance and Future OutlookMay 7, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 3, 2024 | finance.yahoo.comSchrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call TranscriptMay 2, 2024 | markets.businessinsider.comMaintained Buy Rating on Schrodinger: Navigating Short-Term Hurdles with Long-Term Catalysts in SightMay 2, 2024 | markets.businessinsider.comMaintaining Buy Rating on Schrodinger: Solid Fundamentals and Promising Pipeline Despite Quarterly MissMay 1, 2024 | seekingalpha.comSchrödinger, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 1, 2024 | msn.comSchrödinger misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY24 outlookMay 7, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 1, 2024 | finance.yahoo.comSchrodinger Inc (SDGR) Misses Revenue Expectations in Q1 2024May 1, 2024 | businesswire.comSchrödinger Reports First Quarter 2024 Financial ResultsApril 30, 2024 | msn.comSchrödinger Q1 2024 Earnings PreviewApril 18, 2024 | businesswire.comSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 11, 2024 | finance.yahoo.comInstitutional investors must be pleased after a 11% gain last week that adds to Schrödinger, Inc.'s (NASDAQ:SDGR) one-year returnsApril 10, 2024 | businesswire.comSchrödinger to Announce First Quarter 2024 Financial Results on May 1April 2, 2024 | investorplace.com5 Healthcare Stocks to Buy for 2024April 1, 2024 | msn.com9 Noteworthy Stocks in Bill Gates’ PortfolioMarch 27, 2024 | investorplace.comInvest Like Bill Gates With These 3 AI Stocks to BuyMarch 20, 2024 | investorplace.comShhh! 7 Small-Cap Stocks That Can Double by 2025March 1, 2024 | investorplace.comThe Hot List: 3 AI Stocks Worth Buying on WeaknessFebruary 29, 2024 | seekingalpha.comSchrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024February 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for Schrodinger Amidst Robust Software Business and Promising Clinical MilestonesFebruary 29, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Schrodinger (SDGR)February 29, 2024 | finance.yahoo.comSchrödinger, Inc. (NASDAQ:SDGR) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | msn.comShoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionFebruary 28, 2024 | msn.comSchrodinger down 15% after hours on soft 2024 guidanceFebruary 28, 2024 | finance.yahoo.comSchrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial ResultsSee More Headlines Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today5/07/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SDGR CUSIPN/A CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees867Year FoundedN/APrice Target and Rating Average Stock Price Target$42.80 High Stock Price Target$67.00 Low Stock Price Target$26.00 Potential Upside/Downside+80.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$40.72 million Net Margins-75.94% Pretax Margin-88.52% Return on Equity-29.25% Return on Assets-20.60% Debt Debt-to-Equity RatioN/A Current Ratio4.64 Quick Ratio4.64 Sales & Book Value Annual Sales$216.67 million Price / Sales7.92 Cash Flow$0.64 per share Price / Cash Flow36.92 Book Value$7.60 per share Price / Book3.12Miscellaneous Outstanding Shares72,310,000Free Float66,815,000Market Cap$1.72 billion OptionableOptionable Beta1.58 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Ramy Farid Ph.D. (Age 59)CEO, President & Director Comp: $1.06MDr. Richard A. Friesner Ph.D. (Age 71)Co-Founder, Scientific Advisory Chairman and Director Comp: $465kDr. Geoffrey Craig Porges MBBSExecutive VP & CFODr. Robert Lorne Abel Ph.D. (Age 42)Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Comp: $569.45kDr. Karen Akinsanya Ph.D. (Age 56)President of Research & Development Therapeutics Comp: $797.74kDr. Margaret Han Dugan M.D. (Age 67)Chief Medical Officer Comp: $707.46kProf. William Goddard IIICo-Founder & Scientific AdvisorMr. Kenneth Patrick Lorton (Age 40)Executive VP, CTO & COO of Software Comp: $510.09kMr. Shane Brauner (Age 46)Executive VP & Chief Information Officer Ms. Jaren Irene MaddenSenior Vice President of Investor Relations & Corporate CommunicationsMore ExecutivesKey CompetitorsHarmony BiosciencesNASDAQ:HRMYCatalyst PharmaceuticalsNASDAQ:CPRXSyndax PharmaceuticalsNASDAQ:SNDXAgios PharmaceuticalsNASDAQ:AGIOStructure TherapeuticsNASDAQ:GPCRView All CompetitorsInsiders & InstitutionsIllinois Municipal Retirement FundBought 831 shares on 5/7/2024Ownership: 0.044%Redwood Wealth Management Group LLCSold 432 shares on 5/7/2024Ownership: 0.019%Duality Advisers LPBought 6,028 shares on 5/6/2024Ownership: 0.076%Texas Permanent School Fund CorpBought 626 shares on 5/6/2024Ownership: 0.066%Geneos Wealth Management Inc.Bought 15,310 shares on 5/4/2024Ownership: 0.051%View All Insider TransactionsView All Institutional Transactions SDGR Stock Analysis - Frequently Asked Questions Should I buy or sell Schrödinger stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SDGR shares. View SDGR analyst ratings or view top-rated stocks. What is Schrödinger's stock price target for 2024? 9 brokers have issued 12-month target prices for Schrödinger's shares. Their SDGR share price targets range from $26.00 to $67.00. On average, they expect the company's stock price to reach $42.80 in the next twelve months. This suggests a possible upside of 80.4% from the stock's current price. View analysts price targets for SDGR or view top-rated stocks among Wall Street analysts. How have SDGR shares performed in 2024? Schrödinger's stock was trading at $35.80 on January 1st, 2024. Since then, SDGR shares have decreased by 33.7% and is now trading at $23.72. View the best growth stocks for 2024 here. When is Schrödinger's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024. View our SDGR earnings forecast. How were Schrödinger's earnings last quarter? Schrödinger, Inc. (NASDAQ:SDGR) issued its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.12. The business had revenue of $74.10 million for the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a negative net margin of 75.94% and a negative trailing twelve-month return on equity of 29.25%. The company's revenue was up 30.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.39) earnings per share. What ETFs hold Schrödinger's stock? ETFs with the largest weight of Schrödinger (NASDAQ:SDGR) stock in their portfolio include Northern Lights Fund Trust IV - Long Cramer Tracker ETF (LJIM), ARK Genomic Revolution ETF (ARKG), Subversive Mental Health ETF (SANE), TrueShares Technology, AI & Deep Learning ETF (LRNZ), Tema Oncology ETF (CANC), Range Cancer Therapeutics ETF (CNCR), Loncar China Biopharma ETF (CHNA) and Invesco S&P SmallCap Health Care ETF (PSCH). What guidance has Schrödinger issued on next quarter's earnings? Schrödinger issued an update on its FY 2024 earnings guidance on Wednesday, May, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $198.7 million-$214.8 million, compared to the consensus revenue estimate of $206.7 million. What is Ramy Farid's approval rating as Schrödinger's CEO? 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Schrödinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ), Cisco Systems (CSCO), Teladoc Health (TDOC), Alteryx (AYX) and QUALCOMM (QCOM). When did Schrödinger IPO? Schrödinger (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets acted as the underwriters for the IPO. Who are Schrödinger's major shareholders? Schrödinger's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (3.61%), Sumitomo Mitsui Trust Holdings Inc. (3.03%), Nikko Asset Management Americas Inc. (1.78%), Principal Financial Group Inc. (0.39%), Allspring Global Investments Holdings LLC (0.23%) and Duality Advisers LP (0.08%). Insiders that own company stock include David E Shaw, Jenny Herman, Joel Lebowitz, Karen Akinsanya, Kenneth Patrick Lorton, Nancy Thornberry, Ramy Farid, Robert Lorne Abel, Rosana Kapeller-Libermann and Yvonne Tran. View institutional ownership trends. How do I buy shares of Schrödinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SDGR) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBiden replacement revealed?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon Musk Secret Crypto Plot ExposedCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrödinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.